I had my entire DNA read letter by letter — then put it to work. Here's what my longevity genes say, where my genes flag real risk, my ancestry, how my body handles medicines, and what knowing all of it actually changed — written for a curious human, with the clinician-grade detail tucked underneath.
Your DNA is like a 3-billion-letter instruction manual for building and running your body. I had the whole thing read, letter by letter — that's called whole-genome sequencing — then used a bioinformatics pipeline (software that interprets DNA) to translate the useful parts into plain answers I can actually act on. Here's what it told me — and what I did about it.
Methods — 30× whole-genome sequence, GRCh38. Variants annotated with VEP · gnomAD · AlphaMissense · ClinVar. Pharmacogenomics typed with PharmCAT + Aldy (CPIC star alleles). Polygenic scores from the PGS Catalog. mtDNA / Y haplogroups via haplogrep3 + ISOGG. Full variant-level table at the foot of this page ↓
My panel screens the gene families behind the Hallmarks of Aging. Here are the genes with a real, called finding for me — good or bad — each with the variant, my genotype, and why it matters. (Full variant table at the foot of this page.)
FOXO3 is the most-replicated human longevity gene — its protective variant is consistently over-represented in people who reach 100. I carry one copy.
KL-VS is a variant of the "longevity hormone" klotho. One copy is linked to longer life and sharper cognition; two copies would be the unfavorable state — I carry exactly one.
The single biggest inherited influence on Alzheimer's risk. I carry the neutral form — none of the high-risk ε4 variant (and none of ε2). A favorable backdrop for brain aging.
A mostly-inherited cholesterol particle that strongly drives heart-attack and stroke risk — and you can barely move it with lifestyle. Mine sits in the bottom 1%.
Databases flagged two of my PCSK9 variants as possibly tied to high cholesterol, but they're the common, non-disease-causing versions. I confirm with regular lipid panels rather than assume.
The genes that keep my cells' instructions error-free (and guard against cancer) show no damaging variants — no inherited cancer syndrome, despite my parents' cancer history.
Called, but on modest or mixed evidence (genotype reported without overclaiming): mTOR rs2295080 T/T · IGF1 rs35767 G/G + rs6220 A/A · SIRT1 rs3758391 C/C + rs7896005 A/G · SIRT3 rs11246020 C/T + rs3782116 T/C · SIRT6 rs350852 + rs107251 (both hom) · TERT rs7726159 A/A · TP53 codon-72 Pro/Arg rs1042522 G/C. None of these carries a strong, replicated good-or-bad longevity effect like FOXO3 or KL-VS — so I report the genotype but don't grade it. For telomere biology I rely on directly-measured length (LifeLength, SpectraCell) rather than the weak TERT/TERC predictor SNPs.
I don't only show the flattering findings. These are inherited tendencies — polygenic risk scores, like a credit score for a trait, not a verdict — where my numbers run high, and the action each one drives. Tendencies, not fate.
This is the cluster I work hardest against: a strong inherited push toward type-2 diabetes and coronary artery disease (my father's heart risk was at the ceiling). It's why I keep simple carbs low, train hard, and track ApoB and glucose relentlessly.
A blood marker of early Alzheimer's-type change runs mildly high for me — but on my favorable genetics (no APOE ε4), which makes it a modifiable early window, not destiny: sleep, vascular health, inflammation. Acting now, not waiting.
Higher inherited risk for squamous skin cancer and prostate cancer → annual dermatology checks and a tight PSA schedule (my free-PSA is currently reassuring).
Polygenic scores are population-level tendencies, interpreted on European-ancestry distributions (valid for me — see ancestry below). They tell me where to focus; they don't determine outcomes.
My heritage is Italian on my mother's side (Naples / Caserta) and Polish, Croatian & Yugoslav on my father's side. Here's the honest picture of what my DNA does — and doesn't — show about that.
Italian (maternal — Naples / Caserta) + Polish / Croatian / Yugoslav (paternal), from family history and genealogy records.
Two independent methods agree: the commercial test reads 50% Central Italy, and a PCA built from my own family's DNA places me at the exact 50.0% midpoint between my Italian mother and Slavic father — ≈50% Italian (maternal) / ≈50% Polish-Slovenian (paternal) from two completely different approaches. (family PCA: 271,239 SNPs; allele-sharing David–Mom 0.839 ≈ David–Dad 0.840, parents distinct at 0.742.)
Everyone breaks down medicines a little differently — that's why the exact same pill can work great for one person and barely at all for the next. My DNA spells out how my body handles dozens of common drugs (a field called pharmacogenomics), so a doctor can get my dose right the first time instead of guessing. I keep a printed "pharmacy card" to hand any new doctor or pharmacist.
My body is slow to clear a handful of specific medicines (some antibiotics and a couple of older drugs), so they can pile up more than normal. I flag those so a doctor starts low and watches closely. (One of my late parents had a known allergy to one of them — so this fit.)
My DNA carries a variant linked to malignant hyperthermia — a dangerous reaction to certain general anesthetics. It's the single most safety-critical thing in my genome, so I'd hand every anesthesiologist a heads-up: use TIVA, avoid the trigger agents, keep dantrolene on hand.
Statins are common cholesterol pills. Some people get muscle aches from them — my DNA says I'm at low risk of that. Lucky, because a scan later showed I needed one.
I have a super-common, totally harmless trait that makes one liver blood number run a little high. On paper it can look like a liver problem — but it's just how I'm built. Knowing that saves me pointless worry and tests.
A few genes can cause severe, even life-threatening reactions to certain drugs. I checked for the risky ones — I don't carry any.
My complete pharmacogenomic card from whole-genome typing (Aldy + PharmCAT, CPIC-graded). Plain-English on the left; the gene is the technical label.
| How I respond | Drug(s) | Why — and the gene |
|---|---|---|
| 🛑 Avoid | Older tricyclic antidepressants (amitriptyline, imipramine…) | I clear them too fast — weak effect at normal doses; use an alternative. · CYP2C19 ultrarapid |
| 🛑 Avoid | Irinotecan (chemo) | High toxicity risk (severe low white-cell count + diarrhea) — dose-reduce or avoid. · UGT1A1 *28/*28 |
| ⚙️ Adjust | Voriconazole (antifungal) | I clear it too fast — needs a higher dose or an alternative. · CYP2C19 ultrarapid |
| ⚙️ Adjust | Some SSRIs (citalopram, escitalopram, sertraline) | May underperform at standard dose; fluoxetine/paroxetine are fine. · CYP2C19 ultrarapid |
| ⚙️ Adjust | Tacrolimus (transplant) | Builds up in me — start lower and monitor blood levels. · CYP3A5 non-expressor |
| ⚙️ Adjust | Warfarin (blood thinner) | I'd need ~15% more than the standard formula predicts. · CYP4F2 V433M |
| 👁️ Monitor | Sulfa antibiotics (Bactrim) | Slow to clear → higher sensitivity risk; start low, watch blood counts. · NAT2 slow acetylator |
| 👁️ Monitor | Hydralazine, procainamide, isoniazid | Slow clearance → drug-induced-lupus risk (first two); isoniazid liver/nerve risk (take B6). · NAT2 slow |
| 👁️ Monitor | Acid-reflux PPIs (omeprazole…) | May be too weak for me; famotidine is an alternative. · CYP2C19 ultrarapid |
| 👁️ Monitor | Atazanavir (HIV) | Causes harmless jaundice in me (same gene as my benign high bilirubin). · UGT1A1 *28/*28 |
| ✅ Favorable | Clopidogrel (anti-clot) | Better-than-average activation — works well for me. · CYP2C19 ultrarapid |
| ✅ Favorable | Statins | Lower muscle-ache (myopathy) risk than most people. · SLCO1B1 *14/*14 |
| 🧬 Allergy genes | Severe drug-reaction screen | The dangerous severe-reaction alleles (B*15:02, B*57:01, B*58:01, A*31:01…) are all absent. One minor carrier: DRB1*15:01 (rare amoxicillin-clavulanate liver risk). · HLA |
That harmless high blood number? Now I know it's just genetic — so I don't chase it with extra tests.
Knowing I tolerate statins well made the call easy when a scan showed early plaque.
I carry a gene linked to fatty liver — yet my liver scan came back perfectly clean. Lifestyle won.
My higher prostate tendency, plus my parents' cancer history, tells me exactly where to stay vigilant.
My father had macular degeneration — and I inherited the same two risk genes (about 3× higher risk). So I'm on annual eye exams with macular scans, plus eye-protective (AREDS2) nutrients — years before any symptoms.
There's an agreed-upon list of about 80 genes worth checking, because problems in them can be serious but catchable early. I got checked for all of them. The result: I don't carry anything concerning. A few spots looked scary in the raw database, but a closer look showed they're harmless variations that loads of healthy people carry too.
And here's what that list does not include: the common diseases of aging — type-2 diabetes, high blood pressure, COPD, ordinary heart disease. Those aren't single-gene conditions at all; they're a mix of many tiny inherited nudges plus how you live. So none of these 80 will ever be my "genetic destiny." Where I do carry an inherited nudge — like my higher-than-average polygenic risk for type-2 diabetes and heart disease (the cards above) — my genes only load the dice; my daily choices decide the roll. That's the whole point of everything else on this site.
Every called finding above, with rsID, my genotype, GRCh38 locus, effect, and source. 30× WGS unless noted. Effect sizes are population-level associations from the cited literature / scores — not individual guarantees; genotype calls are from my own callset.
| Finding | Gene | Variant · my genotype | Effect / evidence | Source |
|---|---|---|---|---|
| Macular degeneration | CFH | rs1061170 (Y402H) chr1:196690107 · C/T het | ≈2.5–3× AMD OR (heterozygous, CFH alone) | WGS |
| Macular degeneration | ARMS2 | rs10490924 (A69S) chr10:122454932 · G/T het | additive AMD risk with CFH | WGS |
| Macular degeneration | (polygenic) | AMD PRS | 35th pctile — modest; the two large-effect alleles dominate | PGS Catalog |
| Longevity | FOXO3 | rs2802292 chr6:108587315 · G/T het (+ rs2764264 C/T) | 1 copy of longevity-associated G allele (Willcox 2008) | WGS |
| Longevity | KL (klotho) | KL-VS: rs9536314 T/G + rs9527025 G/C · het both | heterozygous KL-VS — beneficial; homozygous would be detrimental (Arking 2002, Dubal 2014) | WGS |
| Alzheimer's | APOE | rs429358 T/T + rs7412 C/C → ε3/ε3 | neutral; ε4 excluded by both parents' rs429358 T/T | WGS |
| Cardiovascular | LPA | Lp(a) PGS003734 (Mack 2024) | 1st percentile — favorable; no rare LPA coding variants | PGS Catalog |
| Cholesterol | PCSK9 | rs2479409 1/1 + rs509504 1/1 | ClinVar Conflicting → benign (gnomAD AF 0.655 / 0.984 = major alleles) | WGS · gnomAD · AlphaMissense |
| Liver / NAFLD | PNPLA3 | rs738409 (I148M) · G/G hom | steatosis-risk allele (~5% EUR are G/G); my observed liver-fat = grade 0 | WGS |
| Prostate | (polygenic) | PGS000662 (Conti 2021) | ~93rd percentile | PGS Catalog |
| Cancer syndromes | BRCA1/2, ATM, TP53, MSH2… | full ClinVar P/LP screen (21,254 variants) | 0 P/LP; 1 benign PTEN p.Cys65Ser (SIFT-tolerated) | WGS · ClinVar |
| Pharmacogenomics | CYP2C19 · UGT1A1 · NAT2 · CYP3A5 · SLCO1B1 · CYP4F2 | *17/*17 · *28/*28 · *5/*6 · *3/*3 · *14/*14 · V433M | CPIC-graded diplotypes (see pharmacy card above) | PharmCAT + Aldy |
| Modest / mixed evidence | MTOR · IGF1 · SIRT1 · TP53 | rs2295080 T/T · rs35767 G/G, rs6220 A/A · rs3758391 C/C, rs7896005 A/G · rs1042522 G/C (codon-72 Pro/Arg) | genotype reported only; associations modest / inconsistent | WGS |
| Ancestry | autosomal + uniparental | AncestryDNA: C.Italy 50% / Poland 40% / Slovenia 8% / NC-Europe 2% · family PCA = 50.0% maternal midpoint (271k SNPs) · mtDNA T2b4+152 · Y R1b-U152 | ≈50% Italian (maternal) / ≈50% Polish-Slovenian (paternal); commercial panel + family PCA concur. Haplogroups = single deep lineages, not ethnicity | AncestryDNA · family PCA · haplogrep3 · ISOGG |